Mila Bölger

Honorary Appointment: Haemato-Oncology Group

I am a MSc student from Leiden University, and I am completing my thesis at the ICR, where I investigate novel therapeutic compounds for acute myeloid leukaemia (AML) by targeting the RNA-binding YTHDF proteins.